During the past decade, Achieve Clinical Research, LLC conducted 34 clinical trials. In the 10-year time frame, 34 clinical trials started and 28 clinical trials were completed, i.e. on average, 82.4% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 10 clinical trials were completed. i.e. 83.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Achieve Clinical Research, LLC" #1 sponsor was "Pfizer" with 10 trials, followed by "Eli Lilly and Company" with 5 trials sponsored, "Boehringer Ingelheim" with 3 trials sponsored, "Purdue Pharma LP" with 3 trials sponsored and "Amgen" with 3 trials sponsored. Other sponsors include 36 different institutions and companies that sponsored additional 41 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Achieve Clinical Research, LLC" #1 collaborator was "CoLucid Pharmaceuticals" with 2 trials as a collaborator, "Incyte Corporation" with 2 trials as a collaborator, "Pfizer" with 2 trials as a collaborator, "Advanced Clinical Research Services, LLC" with 1 trials as a collaborator and "Biomedical Advanced Research and Development Authority" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Achieve Clinical Research, LLC" are "Arthritis, Rheumatoid" (5 trials), "Osteoarthritis" (5 trials), "Alzheimer Disease" (3 trials), "Chronic Pain" (3 trials) and "Osteoarthritis, Knee" (3 trials). Many other conditions were trialed in "Achieve Clinical Research, LLC" in a lesser frequency.

Most popular intervention types in "Achieve Clinical Research, LLC" are "Drug" (51 trials), "Biological" (8 trials), "Other" (7 trials), "Device" (3 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (20 trials), "Baricitinib" (2 trials), "Buprenorphine transdermal delivery system" (2 trials), "Oxymorphone Extended Release" (2 trials) and "RINCE" (2 trials). Other intervention names were less common.

The vast majority of trials in "Achieve Clinical Research, LLC" are 62 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Achieve Clinical Research, LLC". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 51 completed trials in Achieve Clinical Research, LLC, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Achieve Clinical Research, LLC, 3 "Phase 1" clinical trials were conducted, 24 "Phase 2" clinical trials and 30 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 2 trials that are defined as “Not Applicable".

Achieve Clinical Research, LLC has several departments that took part in Clinical trials: "Avail Clinical Research, LLC" - 154 trials, "Accel Research Sites - Nona Pediatric Center" - 2 trials